Calamos Advisors LLC Care Dx, Inc. Transaction History

Calamos Advisors LLC

$16.8 Billion
Q4 2024

A detailed history of Calamos Advisors LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Calamos Advisors LLC holds 87,265 shares of CDNA stock, worth $1.97 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

87,265

Previous 123,402 29.28%

Holding current value

$1.97 Million

Previous $3.85 Million 51.51%

% of portfolio

0.01%

Previous 0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 24, 2025	SELL	$20.4 - $32.2 $737,194 - $1.16 Million	-36,137 Reduced 29.28%	87,265 $1.87 Million
Q3 2024 Nov 07, 2024	BUY	$14.41 - $33.99 $1.78 Million - $4.19 Million	123,402 New	123,402 $3.85 Million
Q4 2021 Feb 01, 2022	SELL	$41.2 - $73.6 $1.45 Million - $2.59 Million	-35,134 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$59.15 - $91.99 $2.4 Million - $3.74 Million	-40,634 Reduced 53.63%	35,134 $2.23 Million
Q2 2021 Jul 22, 2021	BUY	$63.02 - $95.11 $1.92 Million - $2.9 Million	30,448 Added 67.18%	75,768 $6.93 Million
Q1 2021 Apr 12, 2021	SELL	$57.62 - $95.6 $27,484 - $45,601	-477 Reduced 1.04%	45,320 $3.09 Million
Q4 2020 Jan 27, 2021	BUY	$41.43 - $77.09 $95,786 - $178,232	2,312 Added 5.32%	45,797 $3.32 Million
Q3 2020 Oct 26, 2020	BUY	$30.88 - $37.94 $1.34 Million - $1.65 Million	43,485 New	43,485 $1.65 Million
Q4 2019 Jan 15, 2020	SELL	$19.24 - $28.41 $2.14 Million - $3.16 Million	-111,133 Closed	0 $0
Q3 2019 Oct 21, 2019	SELL	$20.03 - $40.08 $1.23 Million - $2.46 Million	-61,371 Reduced 35.58%	111,133 $2.51 Million
Q2 2019 Aug 07, 2019	BUY	$25.78 - $39.77 $4.45 Million - $6.86 Million	172,504 New	172,504 $6.21 Million

Others Institutions Holding CDNA

# of Institutions

218

Shares Held

51M

Call Options Held

97.3K

Put Options Held

43.3K

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.21B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.

Account

Calamos Advisors LLC Care Dx, Inc. Transaction History